# Medication Intelligence Phase 14B Part 3 — Controlled Synthetic Shadow Evaluation

**Certification ID:** `MEDUI.MEDICATION_INTELLIGENCE_PHASE_14B_CONTROLLED_SYNTHETIC_SHADOW_EVALUATION_GAP_ANALYSIS_REPORTING`

**Expected result:** `MEDICATION_INTELLIGENCE_PHASE_14B_CERTIFIED`

---

## Mission

Execute controlled synthetic shadow evaluation against the eight Wave 1 families that are `APPROVED_FOR_SHADOW`, consuming **immutable** `MedicationShadowSnapshot` records and invoking the certified Phase 10 evaluation engine in `SHADOW` mode.

Findings are never exposed to patient-care workflows.

## Permanent boundaries

```text
ApprovedForShadow != ApprovedForProduction
ShadowEvaluable != ClinicallyActive
SyntheticValidation != PatientCare
KnowledgeApproval != MedicationOrderApproval
```

## Reuse

| Layer | Reuse |
|-------|-------|
| Phase 10 | `runShadowSafetyEvaluation` (mode `SHADOW`; executionMode label `SYNTHETIC_SHADOW`) |
| Phase 11 | `MedicationSafetyReferenceSet` / cases / expected findings; gap patterns |
| Phase 13 | Wave key, match classification helpers |
| Phase 14B Parts 1–2 | Expert review, qualifications, immutable snapshots |

## Batch

- Key: `EM_WAVE1_SYNTHETIC_SHADOW_VALIDATION_V1`
- Reference set: `PHASE14B_EM_WAVE1_SYNTHETIC_SHADOW_V1`
- Fixture marker: `PHASE14B_SYNTHETIC_SHADOW_FIXTURE`

## Case package (per family, evidence-honest)

1. Identity guard  
2. Provenance / snapshot integrity  
3. Deferred-domain guard (`DOMAIN_DEFERRED_NOT_EVALUATED`)  
4. Negative expected-no-finding (no DDI/allergy/duplicate)  
5. Knowledge-gap documentation for Tier-1 positive findings (not fabricated)

## Models

`MedicationShadowEvaluationBatch`, `MedicationShadowEvaluationExecution`, `MedicationShadowFindingResult`, `MedicationShadowFamilyResult`, `MedicationShadowGapLink`

## Migration

`20261019120000_medication_phase_14b_controlled_synthetic_shadow_evaluation`

## API / UI / CLI

- API: `/medications/shadow-evaluation/*`  
- UI: `/app/admin/medication-governance/shadow-evaluation`  
- CLI: `medication:shadow-evaluation:*` / `medication:certify:phase14b`

## Non-claims

- Not production CDS  
- Not provider alerts / order blocking  
- Not Tier-1 FDA/DailyMed completion  
- Not acetaminophen identity resolution  
- Not expansion beyond Wave 1  
